Th17 (IFNγ- IL17+) CD4+ T cells generated after burn injury may be a novel cellular mechanism for postburn immunosuppression

Journal of Trauma - Injury, Infection and Critical Care

Volumn 70, Issue 3, 2011, Pages 681-690

  Neely, Crystal J ^a   Maile, Robert ^a   Wang, Ming Jin ^a   Vadlamudi, Sivaram ^a   Meyer, Anthony A ^a   Cairns, Bruce A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Burn injury; IL 17; Immunology; T cells; Th17

Indexed keywords

BUPRENORPHINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SURFACE; BURN; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POLARITY; CELL SELECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNE DEFICIENCY; LYMPH NODE; LYMPHOCYTE CULTURE; MAGNETIC SEPARATION; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; SHAM PROCEDURE; TH1 CELL; TH17 CELL; WOUND DRAINAGE;

ANIMALS; BURNS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNOSUPPRESSION; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; TH17 CELLS;

EID: 79952782174     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31820d18a6     Document Type: Article

References (58)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348-2357. (Pubitemid 16136806)
2. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132. (Pubitemid 41541790)
3. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6: 1133-1141. (Pubitemid 41541791)
4. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. NEngl JMed. 2009;361:888-898.
5. Dragon S, Saffar AS, Shan L, Gounni AS. IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils. Mol Immunol. 2008;45:160-168. (Pubitemid 47331645)
6. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001;194:519-527. (Pubitemid 32835046)
7. Ye P, Garvey PB, Zhang P, et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol. 2001;25:335-340. (Pubitemid 32918915)
8. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of inter-leukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004;190:624-631. (Pubitemid 38982105)
9. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation ofpathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.
10. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006; 441:231-234.
11. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation ofIL-17-producing T cells. Immunity. 2006;24:179-189. (Pubitemid 43214587)
12. + Thelpercells. Cell. 2006;126:1121-1133. (Pubitemid 44380299)
13. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99-146.
14. + T cells in an irradiation model ofhomeostatic proliferation. J Trauma. 2006;61:1062-1068. (Pubitemid 44737008)
15. Cairns BA, Maile R, Buchanan I, et al. CD8 T cells express a T-helper 1-like phenotype after burn injury. Surgery. 2001;130:210-216. (Pubitemid 32721671)
16. Cho K, Adamson LK, Park J, Greenhalgh DG. Burn injury-mediated alterations in cell cycle progression in lymphoid organs of mice. Shock. 2003;19:138-143.
17. Guo Z, Kavanagh E, Zang Y, et al. Burn injury promotes antigen-driven Th2-type responses in vivo. J Immunol. 2003;171:3983-3990. (Pubitemid 37238672)
18. Hultman CS, Cairns BA, deSerres S, Frelinger JA, Meyer AA. Burn injury impairs second-set rejection and CTL reactivity in mice primed by cultured keratinocyte allografts. Transplantation. 1995;60:584-589.
19. + T cells for an augmented T-helper 1 response. Surgery. 1998;124:269-276; discussion 276-267.
20. Kell MR, Kavanaugh EG, Goebel A, Soberg CC, Lederer JA. Injury primes the immune system for an enhanced and lethal T-cell response againstbacterial superantigen. Shock 1999;12:139-144.
21. Maekawa T, Kajihara H, Okabayashi K, Otani M, Yuge O. Impairment of splenic B and T lymphocytes in the early period after severe thermal injury: immunohistochemical and electron microscopic analysis. Burns. 2002;28:329-339. (Pubitemid 34621356)
22. + T cells is a mechanism for effective allogeneic skin graft rejection following burn injury. J Immunol. 2006;176:6717-6726. (Pubitemid 43791968)
23. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg. 2001;193:237-244. (Pubitemid 32834762)
24. + regulatory T cells control innate immune reactivity after injury. J Immunol. 2005;174:2957-2963. (Pubitemid 40279715)
25. Organ BC, Antonacci AC, Chiao J, et al. Changes in lymphocyte number and phenotype in seven lymphoid compartments after thermal injury. Ann Surg. 1989;210:78-89. (Pubitemid 19184450)
26. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg. 1995;222:482-490; discussion 490-482.
27. + T cells. JLeukoc Biol. 2005;77:141-150. (Pubitemid 40315047)
28. Schwacha MG. Macrophages and post-burn immune dysfunction. Burns. 2003;29:1-14. (Pubitemid 36132258)
29. Teodorczyk-Injeyan JA, Cembrzynska-Nowak M, Lalani S, Peters WJ, Mills GB. Immune deficiency following thermal trauma is associated with apoptotic cell death. J Clin Immunol. 1995;15:318-328.
30. Teodorczyk-Injeyan JA, Sparkes BG, Mills GB, Peters WJ. Immuno-suppression follows systemic T lymphocyte activation in the burn patient. Clin Exp Immunol. 1991;85:515-518.
31. Zang Y, Dolan SM, Choileain NN, et al. Burn injury initiates a shift in superantigen-induced T cell responses and host survival. J Immunol. 2004;172:4883-4892. (Pubitemid 38456412)
32. Zedler S, Bone RC, Baue AE, von Donnersmarck GH, Faist E. T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med. 1999;27:66-72. (Pubitemid 29052816)
33. + cells. J Trauma. 1997;42:872-880; discussion 880-881.
34. Kelly JL, O'Sullivan C, O'Riordain M, et al. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury? Ann Surg. 1997;225:530-541; discussion 541-533.
35. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992;216:117-134.
36. Al-Qattan MM. 'Late' multiorgan failure in majorburns: a "three-event" construct ratherthan a "two-event" construct. Burns. 2007;33:268-270.
37. Ogle CK, Mao JX, Wu JZ, Ogle JD, Alexander JW. The 1994 Lindberg Award. The production of tumor necrosis factor, interleukin-1, interleu-kin-6, and prostaglandin E2 by isolated enterocytes and gut macro-phages: effect of lipopolysaccharide and thermal injury. J Burn Care Rehabil. 1994;15:470-477. (Pubitemid 24362545)
38. Wei D, Ge S, Chen Y, Dai F, Su B. Expression of endogenous transforming growth factor-beta and its type I and type II receptors in rat burnwounds. Wound Repair Regen. 1997;5:229-234. (Pubitemid 127689588)
39. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. A relationship between the generation ofburn-associated type 2 T cells and their antagonistic cells in thermally injured mice. Burns. 1997;23:281-287. (Pubitemid 27336288)
40. Hultman CS, Cairns BA, deSerres S, Frelinger JA, Meyer AA. Early, complete burn wound excision partially restores cytotoxic T lymphocyte function. Surgery. 1995;118:421-429; discussion 429-430.
41. Hultman CS, Cairns BA, Yamamoto H, deSerres S, Frelinger JA, Meyer AA. The 1995 Moyer Award. The effect of burn injury on allograft rejection, alloantigen processing, and cytotoxic T-lymphocyte sensitiza-tion. JBurn Care Rehabil. 1995;16:573-580.
42. Ni Choileain N, Macconmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol. 2006;176:225-236. (Pubitemid 43023267)
43. Kataranovski M, Kucuk J, Colic M, et al. Post-traumatic activation of draining lymph node cells. II. Proliferative and phenotypic characteris-tics. Burns. 1994;20:403-408.
44. + T cells. J Immunol. 1988;140:4115-4122.
45. O'Suilleabhain C, O'Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML. Interleukin-12 treatment restores normal resistance to bacterial challenge afterburn injury. Surgery. 1996;120:290-296. (Pubitemid 26287816)
46. Murphey ED, Sherwood ER. Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression. Shock. 2006;26:417-424. (Pubitemid 44402029)
47. Jyonouchi H, Geng L, Cushing-Ruby A, Monteiro IM. Aberrant re-sponses to TLR agonists in pediatric IBD patients; the possible associ-ation with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen. Pediatr Allergy Immunol. 2010;21(4 Pt 2):e747-e755.
48. Cairns B, Maile R, Barnes CM, Frelinger JA, Meyer AA. Increased toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late afterburn injury. JTrauma. 2006;61:293-298; discussion 298-299. (Pubitemid 44265804)
49. Cairns BA, Barnes CM, Mlot S, Meyer AA, Maile R. Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury. J Trauma. 2008;64:1069-1077; discussion 1077-1068. (Pubitemid 351521901)
50. Anders HJ, Banas B, Schlondorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. JAm Soc Nephrol. 2004;15:854-867. (Pubitemid 38375304)
51. Dinarello CA. Infection, fever, and exogenous and endogenous pyro-gens: some concepts have changed. J Endotoxin Res. 2004;10:201-222. (Pubitemid 39481010)
52. Guillot L, Balloy V, McCormack FX, et al. Cutting edge: the immuno-stimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol. 2002;168:5989-5992. (Pubitemid 34620010)
53. Iliev AI, Stringaris AK, Nau R Neumann H. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J. 2004;18: 412-414.
54. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated moni-toring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol. 2002;168:5233-5239. (Pubitemid 34495991)
55. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol. 2004;172:20-24. (Pubitemid 38020450)
56. Kirschning CJ, Schumann RR. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol. 2002; 270:121-144. (Pubitemid 35448157)
57. Marshak-Rothstein A, Busconi L, Rifkin IR, Viglianti GA. The stimu-lation of Toll-like receptors by nuclear antigens: a link between apopto-sis and autoimmunity. Rheum Dis Clin North Am. 2004;30:559-574, ix. (Pubitemid 38917001)
58. Paterson HM, Murphy TJ, Purcell EJ, et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol. 2003;171:1473-1483. (Pubitemid 36900082)